Students impress in Kruh poster competition

The 2020 Gary Kruh Student Poster Competition, sponsored by the University of Illinois Cancer Center, was different than in years past, but the scientific works were no less impactful. Students traditionally enjoy personally showing their work to those interested in learning about it, and answer any questions that may arise. However, due to the COVID-19 pandemic, students were forced to display their work virtually. A panel of judges critiqued the posters and selected…

Continue Reading

Evaluation of Ferroptocide (FTC) As a Potential Treatment For Prostate Cancer Cells

https://cancer.uillinois.edu/wp-content/uploads/2020/10/Hillary-Evaluation-of-Ferroptocide-FTC-As-a-Potential-Treatment-For-Prostate-Cancer-Cells.mp4 Hillary Sanatkumar Shah Mentor: Gnanasekar Munirathinam, PhD The American Cancer Society estimates that 191,930 new cases of prostate cancer will be diagnosed this year, with the disease causing 33,330 deaths, making it the second leading cause of cancer death in American men. Existing treatments for prostate cancer include surgery, radiation therapy, chemotherapy, hormonal therapy and immunotherapy. These treatment options show effects in the beginning stages, but ultimately resistance develops in the majority…

Continue Reading

Role of Hyperandrogenism in the Development of Fallopian Tube Derived High Grade Serous Ovarian Cancer

Jose Colina Mentor: Joanna Burdette, PhD An estimated 22,440 women were diagnosed with ovarian cancer last year. Of those individuals, an estimated 14,080 died of the disease, making ovarian cancer the most lethal gynecologic malignancy in the United States. High grade serous ovarian cancer (HGSOC) is the most common subtype of the disease. If caught early, ovarian cancer has a 92.1% five-year survival rate; however, 79% or more of the individuals are diagnosed…

Continue Reading

Cervical Cancer and High-Risk HPV Strains in Chicago: the importance of the “Other”

https://cancer.uillinois.edu/wp-content/uploads/2020/10/Hoda-E-Sayegh-23_audiopres.mp4 Hoda Sayegh Mentor: Gelila Goba, MD Cervical Cancer and High-Risk HPV Strains in Chicago: the importance of the “Other” The National Health and Nutrition Examination Survey indicates that 20.4% of adult women have High-Risk Human Papilloma Virus (hrHPV). Strains 16 and 18 of the virus are most commonly associated with cervical cancer, but HPV strains 31, 33, 35, 39, 45, 51, 52, 56, 58, 66, and 68 have also been identified as…

Continue Reading

Gemcitabine Resistance Requires the Sustained Uptake of Calcium via L-Type Channels and is Reversed by High Dose Amlodipine

https://cancer.uillinois.edu/wp-content/uploads/2020/10/Daniel-Principe-29_audiopres.mp4 Presenter: Daniel Principe Mentor: Ajay Rana, PhD Gemcitabine Resistance Requires the Sustained Uptake of Calcium via L-Type Channels and is Reversed by High Dose Amlodipine Gemcitabine is among the most widely used medications in the treatment of pancreatic cancer. While Gemcitabine-based chemotherapy modestly prolongs survival in both localized and disseminated disease, nearly all tumors either have or will develop some degree of drug resistance. With no approved medications for patients who progress…

Continue Reading

Engaging Multi-Sector Stakeholders to Enhance Support for Young Breast Cancer Survivors: Results of a Virtual Participatory Design Workshop

https://cancer.uillinois.edu/wp-content/uploads/2020/10/Asha-Matthew-26_audiopres.mp4 Presenter: Asha Solomon Mentor: Ardith Doorenbos, PhD, RN Engaging Multi-Sector Stakeholders to Enhance Support for Young Breast Cancer Survivors: Results of a Virtual Participatory Design Workshop Young and A Survivor (YAAS!) is a diverse network of 30 clinical/academic partners, community-based organizations, and young breast cancer survivors dedicated to enhancing support for young women aged 18-45 who are affected by breast cancer. With an emphasis on young survivors in underserved/under-represented communities, YAAS! takes…

Continue Reading

Jag1 as a Novel Extravasation Factor During Triple Negative Breast Cancer Metastasis

https://cancer.uillinois.edu/wp-content/uploads/2020/10/Benjamin-Gordon-20_audiopres.mp4 Presenter: Benjamin Gordon Mentor: Jan Kitajewski, PhD Breast cancer is the second leading cause of cancer-related mortality in women. The primary tumor doesn’t normally cause death, but the spread of the disease does. Up to 20% of breast cancer diagnoses are triple negative breast cancer (TNBC), and the five-year survival rate for the disease in its late stages is as low as 11%. TNBC is unresponsive to hormonal and targeted therapies of…

Continue Reading

COVID-19 forced Zink out of lab, but cancer research didn’t stop

A pandemic has not stopped University of Illinois at Chicago graduate student Katherine Zink from trying to find a cure for ovarian cancer, or from simultaneously earning a doctorate degree in natural products chemistry. The recipient of the Ruth L. Kirschstein Predoctoral Individual National Research Service Award from the National Institutes of Health (NIH), Zink was forced to physically distance herself from the laboratory of her mentor, Laura Sanchez, for nearly three months…

Continue Reading

New cancer educational program pairs scientists, survivors

Scientists are searching for any way to find a cure for cancer, and who better to help them than those who have battled the disease.University of Illinois College of Medicine MD/PhD students are teaming up with patient advocates to create an educational program that connects young investigators with cancer patients, survivors, research advocates, and allies to increase their scientific knowledge.“Our goal is to bring everyone to the table for discussions related to the…

Continue Reading

Call for Abstracts – Dr. Gary Kruh Cancer Research Student Poster Competition

Share on facebook Facebook Share on twitter Twitter Submit posters here Deadline for poster submission is Friday, March 13.Use password kruhposter2020 to registerUIC students and fellows are invited to submit posters highlighting their cancer-focused research for the Dr. Gary Kruh Cancer Research Student Poster Competition 2020. Posters may be submitted under topics relevant to the UI Cancer Center's three programs: Cancer Biology, Cancer Prevention and Control, Translational Oncology.This annual event, named for former…

Continue Reading